
Remaining calm, cool, and collected during mergers and inspections is a feat in itself.

Remaining calm, cool, and collected during mergers and inspections is a feat in itself.

The author examines the process of method development, with reference to ISO 13320:2009 and relevant monographs from the United States and European pharmacopoeias.

The authors present an update to the Wyeth/BASF experience with the IPEC Novel Excipient Safety Evaluation Procedure.

Applied statisticians are forever searching for the enemy of quality-variability.

Pharmaceutical Technology Europe
There has been increasing cooperation between the EMA and the FDA in recent years, and this looks set to continue in the future.

ePT--the Electronic Newsletter of Pharmaceutical Technology
PPD and Bend Research Form Collaboration; Ricerca Makes Senior Appointment; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration issued a draft guidance last week on the Qualification Process for Drug Development Tools.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Pharmacopeia (USP) has announced two new collaborations.

As part of a team, you will prepare meetings of European Pharmacopoeia groups of experts, contribute to the preparation of working documents for these groups, contribute to the elaboration and revision of European Pharmacopoeia texts and follow up meetings with a view to publication of scientific texts and memoranda.

As part of the Certification team, you will evaluate dossiers submitted with requests for revision of certificates of suitability to the European Pharmacopoeia and prepare draft reports; you will ensure consistency of assessment reports for similar products and consistency of the reports with the policy of the procedure, if necessary analysing and reporting any discrepancies.

ePT--the Electronic Newsletter of Pharmaceutical Technology
During Oct. 5-12, 2010, more than 40 countries cooperated in an international week of action to combat the online sale of counterfeit and illegal drugs and to raise awareness of their associated health risks.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Generic medicines Association (EGA) has made a number of recommendations on how to ensure the quality of medicines in the globalized supply chain; in particular, the EGA spoke about API quality and quality supervision, and how these can be improved by transparent communication between authorities and industry.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration has posted on its website the minutes of the PDUFA V reauthorizaton stakeholder meeting.

Equipment and Processing Report
Jeffrey Hartry, director of quality systems and information at Cangene (Winnipeg, Canada), talks about his company?s conversion from a paper-based to an electronic training-management system.

ePT--the Electronic Newsletter of Pharmaceutical Technology
sanofi to Cut 25% of US Workforce; AMRI Names VP of Chemical Development; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration has released an implementation report on its Regulatory Science Initiative. The report outlines the agency's plans to advance regulatory science through new tools, standards, and approaches for assessing the safety, efficacy, quality and performance of FDA-regulated products, according to an agency press release.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Medicines Agency (EMA) has adopted new policies on access to documents and the handling of conflicts of interest

ePT--the Electronic Newsletter of Pharmaceutical Technology
FDA to Hold Public Hearing on Biosimilars Legislation, And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Pharmacopeia released a statement this week that explains in more detail last January's recall of the United States Pharmacopeia 33–National Formulary 28 (USP 33–NF 28).

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Novartis Settles with US Attorney's Office; Hospira Names VP, And More.

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.

Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.

From disagreement to denial, being cordial about quality control can be challenging.

In light of compendial changes, representatives of the US Pharmacopeia and an industry consortium provide perspectives on cap and ferrule labels.

President Obama and HHS eye innovation and countermeasures to protect public health.